Alanazi, F.; Alsaleh, A.A.; Alamoudi, M.K.; Alasiri, A.; Haymond, A.; Matou-Nasri, S.
Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer. Biomedicines 2025, 13, 612.
https://doi.org/10.3390/biomedicines13030612
AMA Style
Alanazi F, Alsaleh AA, Alamoudi MK, Alasiri A, Haymond A, Matou-Nasri S.
Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer. Biomedicines. 2025; 13(3):612.
https://doi.org/10.3390/biomedicines13030612
Chicago/Turabian Style
Alanazi, Fatimah, Abdulmonem A. Alsaleh, Mariam K. Alamoudi, Abdulrahman Alasiri, Amanda Haymond, and Sabine Matou-Nasri.
2025. "Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer" Biomedicines 13, no. 3: 612.
https://doi.org/10.3390/biomedicines13030612
APA Style
Alanazi, F., Alsaleh, A. A., Alamoudi, M. K., Alasiri, A., Haymond, A., & Matou-Nasri, S.
(2025). Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer. Biomedicines, 13(3), 612.
https://doi.org/10.3390/biomedicines13030612
